Z-DQMD-FMK merges a Z-protected sequence with a DQMD motif and FMK reactive group. The construct is useful for probing protease specificity, catalytic rates, and irreversible inhibition. Researchers apply it to characterize enzyme recognition pockets and substrate interactions. Its defined structure supports high-precision enzymology.
CAT No: HB00051
Z-DQMD-FMK is a synthetic peptide-based caspase inhibitor that plays a critical role in the study of programmed cell death and apoptotic pathways. Structurally, it features a benzyloxycarbonyl (Z) group, a tetrapeptide recognition sequence (Asp-Gln-Met-Asp), and a fluoromethyl ketone (FMK) reactive group, which confers irreversible inhibitory activity against caspase-3 and related cysteine proteases. Widely utilized in biochemical and cell biology research, Z-DQMD-FMK enables precise modulation of caspase activity, supporting the elucidation of apoptotic mechanisms and downstream signaling events. Its specificity and cell-permeable properties make it an indispensable tool for dissecting the molecular underpinnings of cell death in various experimental systems.
Apoptosis research: Z-DQMD-FMK is extensively employed in apoptosis studies to selectively inhibit caspase-3, a key executioner protease in the apoptotic cascade. By blocking caspase-3 activity, researchers can investigate the consequences of caspase inhibition on chromatin condensation, DNA fragmentation, and membrane blebbing. This approach facilitates the differentiation between caspase-dependent and caspase-independent cell death pathways, providing critical insights into the regulation of cell fate and the molecular checkpoints governing apoptosis.
Signal transduction analysis: The compound serves as a valuable reagent for dissecting intracellular signaling networks involving caspase activation. By applying Z-DQMD-FMK to cultured cells or in vitro systems, investigators can temporally control caspase activity and monitor the impact on downstream effectors such as PARP cleavage, mitochondrial membrane potential changes, and release of cytochrome c. Such studies are instrumental in mapping the sequence of molecular events during stress responses, immune signaling, and developmental processes where caspase activity is pivotal.
Protease substrate validation: In the context of protease research, Z-DQMD-FMK provides a means to validate the substrate specificity of caspase-3 and related enzymes. By irreversibly binding to the active site, the inhibitor allows researchers to confirm whether observed proteolytic events are attributable to caspase-3 or other cysteine proteases. This specificity is particularly valuable in studies aiming to identify novel caspase substrates or to distinguish overlapping proteolytic activities in complex biological samples.
Cell-based assay development: The inhibitor is routinely incorporated into cell-based assays designed to quantify or modulate caspase activity. Its use enables the establishment of robust positive and negative controls in high-throughput screening platforms, facilitating the identification of modulators of apoptosis or caspase function. Additionally, the compound supports the optimization of assay conditions by providing a reliable means to suppress background caspase activity and enhance signal specificity.
Neurodegeneration and toxicology models: Z-DQMD-FMK is also applied in experimental models of neurodegeneration and chemical toxicity, where caspase-3-mediated cell death is implicated. By blocking apoptotic protease activity, researchers can evaluate the contribution of caspase-dependent mechanisms to neuronal loss or tissue damage following exposure to toxicants, oxidative stress, or genetic manipulation. These studies are essential for unraveling disease mechanisms and identifying potential targets for intervention in neurobiological and toxicological research contexts.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More